U.S., Oct. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07215559) titled 'A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes' on Oct. 09.

Brief Summary: The purpose of this study is to investigate weight reduction with macupatide and eloralintide, alone or in combination, in adult participants with obesity or overweight and with type 2 diabetes. Participation in the study will last about 48 weeks.

Study Start Date: Nov., 2025

Study Type: INTERVENTIONAL

Condition: Obesity Overweight Diabetes Mellitus, Type 2

Intervention: DRUG: Macupatide

Administered SC

DRUG: Eloralintide

Administered SC

DRUG: Mac...